Work

Supplementary Tables 1 - 3 from Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 118K, Supplemental Data Table 1: Additional Eligibility Criteria. Supplemental Table 2: Drugs that are generally accepted as having a risk of causing Torsades de Pointes and were restricted during enrollment on this clinical trial. Supplemental Table 3: Schedule of Required Evaluations.

DOI: 10.1158/1078-0432.22447518

Authors: Elizabeth Fox, Brigitte C. Widemann, Meredith K. Chuk, Leigh Marcus, Alberta Aikin, Patricia O. Whitcomb, Maria J. Merino, Maya Lodish, Eva Dombi, Seth M. Steinberg, Samuel A. Wells, Frank M. Balis

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361881990

Cites:

Cited by:

Related to: 10